Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
Submitted by
admin
on March 26, 2011 - 10:10am
Source:
Yahoo/BusinessWire
News Tags:
Merck
Zostavax
shingles
Headline:
ADDING and REPLACING FDA Expands Indication for ZOSTAVAX®, Merck’s Shingles Vaccine, to Include Adults Ages 50 to 59
Do Not Allow Advertisers to Use My Personal information
